AFACTT network continues after closing sucessfully COST project

Share itShare on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Print this pageEmail this to someone

A total of 21 European countries and the United States have participated in the AFACTT Project, the largest European network in tolergenic cellular therapies. From the project, which concluded with a conference at the IGTP and in Barcelona in October 2017 a total of 9 proposals and new projects have resulted from the activities of AFACTT,

An important spin-off of the AFACTT network is the new project RESTORE (H2020 779316), an international clinical trial of the therapy developed in the laboratory of Dr Martínez-Cáceres and Dr Ramo, coordinated by the University of Amberes and in which the IGTP is participating.

Please find here a full version of the press release issued by IGTP (badalona, Spain), grantholder of the AFACTT project

Comments are closed